Suppr超能文献

[脓毒症大鼠高迁移率族蛋白B1基因表达调控中信号转导通路的潜在机制]

[The potential mechanism on signal transduction pathway in regulation of mRNA expression of high mobility group box-1 protein in septic rats].

作者信息

Yao Yong-ming, Wang Song-bai, Xian Li-ming, Zhai Xiu-zhen, Dong Ning, Yu Yan, Sheng Zhi-yong

机构信息

Burns Institute, First Hospital Affiliated to the People's Liberation Army General Hospital, Beijing 100037, China.

出版信息

Zhonghua Wai Ke Za Zhi. 2006 Jul 1;44(13):916-20.

Abstract

OBJECTIVE

To investigate the potential role of Janus kinase/signal transducer and activator of transcription (JAK/STAT) pathway in regulation of gene expression of high mobility group box-1 protein (HMGB1) in various tissues in rats with sepsis.

METHODS

A sepsis model reproduced by cecal ligation and puncture (CLP), and 128 male Wistar rats were randomly divided into normal control group (n = 10), sham operation group (n = 10), CLP group (n = 60), AG490 treatment group (n = 24), and rapamycin (RPM) treatment group (n = 24). At serial time points animals in each group were sacrificed after CLP, then tissue samples were harvested to determine HMGB1 mRNA expression and STAT1/3 DNA binding activity.

RESULTS

STAT1 activities increased rapidly in the liver, lungs and small intestine after CLP, peaking at 6 - 12 h, while it increased slowly, and still kept at mild level from 2 to 48 h in the kidneys. Compared with STAT1, lower STAT3 activities were detected only in the liver and lungs, with negative detection in the small intestine and kidneys. HMGB1 mRNA levels significantly increased in liver, lungs and small intestine at various time points after CLP respectively (P < 0.05 or P < 0.01), while they didn't change in the kidneys. Treatment with AG490 could markedly inhibit HMGB1 mRNA expression in the liver and small intestine at 24 and 48 h (P < 0.05 or P < 0.01), and in lungs at 2 h following CLP (P < 0.01). Similarly, treatment with RPM significantly decreased HMGB1 mRNA expression in the lungs at 2, 6, 24 and 48 h, in the liver at 6 and 24 h, and in the small intestine at 24 and 48 h (P < 0.05 or P < 0.01). In addition, STAT1 and STAT3 activities in the liver and lungs were significantly correlated with corresponding tissue HMGB1 mRNA expression.

CONCLUSIONS

Peritoneal infection could extensively activate STAT1 and limitedly activate STAT3 in vital organs. Activation of JAK/STAT pathway might be involved in up-regulating the gene expression of HMGB1 and systemic inflammation secondary to severe septic challenge.

摘要

目的

探讨Janus激酶/信号转导及转录激活因子(JAK/STAT)通路在脓毒症大鼠各组织中对高迁移率族蛋白B1(HMGB1)基因表达调控中的潜在作用。

方法

采用盲肠结扎穿孔术(CLP)复制脓毒症模型,将128只雄性Wistar大鼠随机分为正常对照组(n = 10)、假手术组(n = 10)、CLP组(n = 60)、AG490治疗组(n = 24)和雷帕霉素(RPM)治疗组(n = 24)。在CLP术后的连续时间点处死每组动物,然后采集组织样本,测定HMGB1 mRNA表达及STAT1/3 DNA结合活性。

结果

CLP术后,肝脏、肺和小肠中的STAT1活性迅速升高,在6 - 12小时达到峰值,而肾脏中的STAT1活性升高缓慢,在2至48小时仍维持在较低水平。与STAT1相比,仅在肝脏和肺中检测到较低的STAT3活性,在小肠和肾脏中未检测到。CLP术后各时间点,肝脏、肺和小肠中的HMGB1 mRNA水平分别显著升高(P < 0.05或P < 0.01),而肾脏中的HMGB1 mRNA水平未发生变化。AG490治疗可在CLP术后24和48小时显著抑制肝脏和小肠中的HMGB1 mRNA表达(P < 0.05或P < 0.01),在CLP术后2小时显著抑制肺中的HMGB1 mRNA表达(P < 0.01)。同样,RPM治疗在CLP术后2、6、24和48小时显著降低肺中的HMGB1 mRNA表达,在6和24小时显著降低肝脏中的HMGB1 mRNA表达,并在24和48小时显著降低小肠中的HMGB1 mRNA表达(P < 0.05或P < 0.01)。此外,肝脏和肺中的STAT1和STAT3活性与相应组织中的HMGB1 mRNA表达显著相关。

结论

腹腔感染可在重要器官中广泛激活STAT1并有限激活STAT3。JAK/STAT通路的激活可能参与上调HMGB1的基因表达及严重脓毒症激发后的全身炎症反应。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验